Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction of Mixed Chimerism in Severe Aplastic Anemia Patients With COH-MC-17
NCT05757310Phase 1Recruiting
- Sponsor
- City of Hope
- Start
- Nov 2024
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in aplastic anemia, sponsored by City of Hope. Primary endpoints: Incidence of adverse events, Ability to meet CD4+ T-cell depleted product release requirements up to 3 years and 1 more. Started Nov 2024; status: recruiting.
02
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT05757310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05757310.